![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
G Maura, A Giardi and M Raiteri
Istituto di Farmacologia e Farmacognosia, Universita degli Studi di Genova, Italy.
The effects of dopamine (DA) and other dopaminergic receptor agonists on the depolarization-evoked release of endogenous glutamic acid (GLU) have been studied using synaptosomes prepared from rat corpus striatum and depolarized in superfusion with 15 mM KCl. DA and the selective D-2 receptor agonists quinpirole (LY-171555, the levorotatory enantiomer of LY-141865) and pergolide inhibited GLU release in a concentration- dependent way. The natural agonist was particularly effective causing 50% inhibition of GLU release at 10 nM. In contrast, the selective D-1 receptor agonist SK&F 38393 did not affect the release of GLU. The inhibitory effect of DA on the K+-evoked release of GLU was antagonized in a concentration-dependent manner by the selective D-2 receptor antagonist S-sulpiride, but not by the R-enantiomer. The data represent a direct demonstration that receptors sensitive to nanomolar concentrations of DA and belonging to the D-2 type are located on GLU axon terminals in the rat corpus striatum where they may modulate the release of GLU from glutamatergic afferents including the cortico- striatal pathway.
This article has been cited by other articles:
|
|
 |
|
  M. J. Frank Dynamic Dopamine Modulation in the Basal Ganglia: A Neurocomputational Account of Cognitive Deficits in Medicated and Nonmedicated Parkinsonism J. Cogn. Neurosci., January 1, 2005; 17(1): 51 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Bamford, S. Robinson, R. D. Palmiter, J. A. Joyce, C. Moore, and C. K. Meshul Dopamine Modulates Release from Corticostriatal Terminals J. Neurosci., October 27, 2004; 24(43): 9541 - 9552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Centonze, A. Usiello, C. Costa, B. Picconi, E. Erbs, G. Bernardi, E. Borrelli, and P. Calabresi Chronic Haloperidol Promotes Corticostriatal Long-Term Potentiation by Targeting Dopamine D2L Receptors J. Neurosci., September 22, 2004; 24(38): 8214 - 8222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Rosenkranz and A. A. Grace Dopamine Attenuates Prefrontal Cortical Suppression of Sensory Inputs to the Basolateral Amygdala of Rats J. Neurosci., June 1, 2001; 21(11): 4090 - 4103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cepeda, R. S. Hurst, K. L. Altemus, J. Flores-Hernandez, C. R. Calvert, E. S. Jokel, D. K. Grandy, M. J. Low, M. Rubinstein, M. A. Ariano, et al. Facilitated Glutamatergic Transmission in the Striatum of D2 Dopamine Receptor-Deficient Mice J Neurophysiol, February 1, 2001; 85(2): 659 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Rosenkranz and A. A. Grace Modulation of Basolateral Amygdala Neuronal Firing and Afferent Drive by Dopamine Receptor Activation In Vivo J. Neurosci., December 15, 1999; 19(24): 11027 - 11039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Westwood and G. R. Hanson Effects of Stimulants of Abuse on Extrapyramidal and Limbic Neuropeptide Y Systems J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1160 - 1166. [Abstract] [Full Text]
|
|
|
|
|
|
V. L. Arvanov, X. Liang, J. Schwartz, S. Grossman, and R. Y. Wang Clozapine and Haloperidol Modulate N-Methyl-D-aspartate- and Non-N-Methyl-D-aspartate Receptor-Mediated Neurotransmission in Rat Prefrontal Cortical Neurons In Vitro J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 226 - 234. [Abstract] [Full Text]
|
|
|
|
|
|
P. Calabresi, A. Saiardi, A. Pisani, J.-H. Baik, D. Centonze, N. B. Mercuri, G. Bernardi, and E. Borrelli Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors J. Neurosci., June 15, 1997; 17(12): 4536 - 4544. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
